Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic…

By R. Verhaak, Chantal S. Goudswaard, W. van Putten, Maarten A. Bijl, M. Sanders, W. Hugens, A. Uitterlinden, Claudia A J Erpelinck, R. Delwel, B. Löwenberg and 1 more. Blood, 2005

667 citations recorded by the source corpus.

Subfields: Hematology, Molecular Biology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/56fa73cbf7b93b48ad1d535404fc0becd845ba48

Citations in the corpus

• Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). (2006, neutral): “Median platelet count, 109/L (range) 68 (7-302)* 56 (3-514) 47 (5-372) 46 (4-1430)”